Cargando…
Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?
OBJECTIVE: The 340B Drug Pricing Program allows hospitals to purchase covered drugs at a discount and potentially generate profit if they are reimbursed at rates that exceed 340B acquisition prices. Disproportionate share hospitals (DSH) are eligible to participate in 340B if their DSH adjustment–a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176719/ https://www.ncbi.nlm.nih.gov/pubmed/34082835 http://dx.doi.org/10.1186/s13104-021-05642-4 |